{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:15:01Z","timestamp":1788992101696,"version":"build-2803163510"},"reference-count":103,"publisher":"Ubiquity Press, Ltd.","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"DOI":"10.1016\/j.gheart.2013.08.011","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T21:18:35Z","timestamp":1380230315000},"page":"227","source":"Crossref","is-referenced-by-count":60,"title":["Benzathine Penicillin G for the Management of RHD: Concerns About Quality and Access, and Opportunities for Intervention and Improvement"],"prefix":"10.5334","volume":"8","author":[{"given":"Rosemary","family":"Wyber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Marko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2013,9,1]]},"reference":[{"key":"10.1016\/j.gheart.2013.08.011_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gheart.2013.08.011_bib2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1952.03680160021005","article-title":"Prophylaxis against group A streptococcal infection in rheumatic fever patients: use of new repository penicillin preparation","volume":"150","author":"Stollerman","year":"1952","journal-title":"JAMA"},{"key":"10.1016\/j.gheart.2013.08.011_bib3","unstructured":"Manyemba J, Mayosi B. Penicillin for secondary prevention of rheumatic fever [pdf]. October 7, 2009. Available at: http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD002227\/pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib4","first-page":"285","article-title":"The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project","volume":"59","author":"Strasser","year":"1981","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.gheart.2013.08.011_bib5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2013.08.011_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-60-2-31","volume":"60","author":"Wood","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gheart.2013.08.011_bib7","unstructured":"Heart Foundation of New Zealand and The Cardiac Society of Australia and New Zealand. New Zealand Guidelines for Rheumatic Fever [pdf]. June 2006. Available at: http:\/\/www.heartfoundation.org.nz\/uploads\/Rheumatic%20fever%20guideline%201(2).pdf Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib8","unstructured":"World Heart Federation. Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease [pdf]. October 2008. Available at: http:\/\/www.world-heart-federation.org\/fileadmin\/user_upload\/documents\/RHD-net\/RHD%20Curriculum.Oct.2008.pdf Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib9","unstructured":"World Health Organization. Rheumatic Fever and Rheumatic Heart Disease. WHO Technical Report Series 923 [pdf]. 2001. Available at: http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_923.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib10","unstructured":"RHD Australia (ARF\/RHD Writing Group), National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand Australian Guideline for Prevention, Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease. 2nd edition [pdf]. 2012. Available at: http:\/\/www.rhdaustralia.org.au\/sites\/default\/files\/guideline_0.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib11","unstructured":"Western Cape Government, South Africa. National Guidelines on Primary Prevention and Prophylaxis of Rheumatic Fever (RF) and Rheumatic Heat Disease (RHD) for Health Professionals at Primary Level [pdf]. 2003. Available at: http:\/\/www.kznhealth.gov.za\/chrp\/documents\/Guidelines\/Guidelines%20National\/Rheumatic%20Heart%20Disease\/Rheumatic%20heart%20disease%20ndoh.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib12","unstructured":"King Pharmaceuticals. Bicillin-LA (penicillin g benzathine) Injection, Suspension. Archived drug label. 2007. Available at: http:\/\/dailymed.nlm.nih.gov\/dailymed\/archives\/fdaDrugInfo.cfm?archiveid=5765. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib13","unstructured":"Pfizer. Bicillin L-A [pdf]. 2009. Available at: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=691. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM195505122521901","article-title":"Prophylaxis against group A strepotocci in rheumatic fever: the use of single monthly injections of benzathine penicillin G","volume":"252","author":"Stollerman","year":"1955","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2013.08.011_bib15","first-page":"1","article-title":"Benzathine penicillin\u2014down but not out","volume":"13","author":"Currie","year":"2006","journal-title":"Northern Territory Dis Control Bull"},{"key":"10.1016\/j.gheart.2013.08.011_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.22.1.128","article-title":"Penicillin-resistant and penicillin-tolerant mutants of group A streptococci","volume":"22","author":"Gutmann","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gheart.2013.08.011_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/516375","article-title":"Why have group A streptococci remained susceptible to penicillin? Report on a symposium","volume":"26","author":"Horn","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gheart.2013.08.011_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00006454-199805000-00006","article-title":"Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades","volume":"17","author":"Macris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.gheart.2013.08.011_bib19","first-page":"S1","article-title":"Evidence-based guidelines for the management of Lyme disease","volume":"2","author":"Cameron","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.gheart.2013.08.011_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babeiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gheart.2013.08.011_bib21","first-page":"21","article-title":"Penicillin prophylaxis for sick cell disease","volume":"87","author":"Nascimento-Caralho","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.gheart.2013.08.011_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1542\/peds.97.6.992","article-title":"Rheumatic fever prophylaxis using benzathine penicillin G (BPG): Two-week versus four-week regimes: comparisons of two brands of BPG","volume":"97","author":"Kassem","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.gheart.2013.08.011_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3476(86)81009-5","article-title":"Rheumatic fever recurrences: controlled study of 3-week versus 4-week benzathine penicillin prevention programs","volume":"108","author":"Lue","year":"1986","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gheart.2013.08.011_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-3476(06)80188-5","article-title":"Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks","volume":"125","author":"Lue","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gheart.2013.08.011_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1440-1754.2010.01942.x","article-title":"Rheumatic fever recurrence prevention: A nurse-led programme of 28-day penicillin in an area of high endemnicity","volume":"47","author":"Spinetto","year":"2011","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.gheart.2013.08.011_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCOUTCOMES.111.000032","article-title":"Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis","volume":"6","author":"Irlam","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.gheart.2013.08.011_bib27","series-title":"Group A streptococcal infections, in Red Book 2006: Report of the Committee on Infectious Diseases","first-page":"610","year":"2006"},{"key":"10.1016\/j.gheart.2013.08.011_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0022-3476(80)80178-8","article-title":"The group A streptococcal upper respiratory tract carrier state: an enigma","volume":"97","author":"Kaplan","year":"1980","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gheart.2013.08.011_bib29","unstructured":"World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections [pdf]. 2001. Available at: http:\/\/whqlibdoc.who.int\/hq\/2001\/WHO_HIV_AIDS_2001.02.pdf. Accessed."},{"issue":"Suppl 3","key":"10.1016\/j.gheart.2013.08.011_bib30","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2458-11-S3-S9","article-title":"Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality","volume":"11","author":"Blencowe","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.gheart.2013.08.011_bib31","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.gheart.2013.08.011_bib32","doi-asserted-by":"crossref","unstructured":"Bai Z, Wang B, Yang K, et\u00a0al., Azithromycin vs penicillin G benzathine for early syphilis, in Cochrane Review. 2012. Available at:. Accessed.","DOI":"10.1002\/14651858.CD007270.pub2"},{"key":"10.1016\/j.gheart.2013.08.011_bib33","series-title":"Informal Consultation on Endemic Treponematoses: Report of an Informal Consultation, Geneva, Switzerland, 6\u20137 July 1995. Technical Report WHO\/EMC\/95.3","author":"World Health Organization","year":"1995"},{"key":"10.1016\/j.gheart.2013.08.011_bib34","unstructured":"World Health Organization. Yaws. Fact sheet no. 316. October 2012. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs316\/en\/. Accessed May 15,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/cid\/cis444","article-title":"New treatment schemes for yaws: the path toward eradication","volume":"55","author":"Mitj\u00e0","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gheart.2013.08.011_bib36","first-page":"160","article-title":"Benzathine penicillin in the management of treponematoses","volume":"31","author":"Guthe","year":"1955","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.gheart.2013.08.011_bib37","series-title":"Stabilized Benzathine Penicillin Compositions. U.S. Patent 3351527","author":"Apat","year":"1967"},{"key":"10.1016\/j.gheart.2013.08.011_bib38","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jama.1954.02950160057023","article-title":"Benzathine penicillin G","volume":"156","author":"Wright","year":"1954","journal-title":"JAMA"},{"key":"10.1016\/j.gheart.2013.08.011_bib39","first-page":"6","article-title":"Availability of benzathine penicillin (reply)","volume":"23","author":"Lan","year":"2006","journal-title":"inTouch"},{"key":"10.1016\/j.gheart.2013.08.011_bib40","unstructured":"Loudon J. Pan benzathine penicillin protocol. Department of Health and Community Services; 2006. Available at: http:\/\/www.carpa.org.au\/Pan%20Benz%20advocacy%20memo%20final.pdf. Accessed September 4, 2013."},{"key":"10.1016\/j.gheart.2013.08.011_bib41","unstructured":"Hebi Huari Pharmaceuticals. Introduction [web page]. 2010. Available at: http:\/\/www.huari-pharm.com\/en\/view.aspx?cid=46. Accessed January 27,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib42","unstructured":"UNICEF, WHO. Sources and prices of selected medicines for children. 2nd edition. April 2010. Available at: http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/Sources_Prices2010.pdf. Accessed September 4, 2013."},{"key":"10.1016\/j.gheart.2013.08.011_bib43","unstructured":"Australian Government, Department of Health and Aging. Schedule of Pharmaceutical Benefits: Summary of Changes [pdf]. August 1, 2008. Available at: http:\/\/www.pbs.gov.au\/publication\/schedule\/2008\/2008-08-01-general-schedule-soc.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib44","first-page":"4","article-title":"Benzathine penicillin","volume":"23","author":"Schultz","year":"2006","journal-title":"inTouch"},{"key":"10.1016\/j.gheart.2013.08.011_bib45","first-page":"6","article-title":"Statement regarding Bicillin L-A (Reply)","volume":"23","author":"Anonymous","year":"2006","journal-title":"inTouch"},{"key":"10.1016\/j.gheart.2013.08.011_bib46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00006454-200406000-00028","article-title":"Benzathine penicillin formulations","volume":"23","author":"Kaplan","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.gheart.2013.08.011_bib47","unstructured":"HIV, STD and Hepatitis Prevention Branch, Public Health Services, Health and Human Services Agency, County of San Diego. Information regarding availability of benzathine penicillin [memo]. June 22, 2005. Available at: http:\/\/www.sdcounty.ca.gov\/hhsa\/programs\/phs\/documents\/STDHEP17.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib48","unstructured":"Anonymous. King Pharmaceuticals Announces FDA Approval of New\u00a0Bicillin\u00ae Manufacturing Facility [press release]. February 21, 2007. Available at: http:\/\/finance.boston.com\/boston\/news\/read\/1410647\/king_pharmaceuticals_announces_fda_approval_of_new_bicillin. Accessed January 26,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib49","series-title":"Pfizer to buy King Pharmaceuticals for $3.6 Billion","author":"Sorkin","year":"2010"},{"key":"10.1016\/j.gheart.2013.08.011_bib50","series-title":"The Impact of War on Child Health in the Countries of the Former Yugoslavia. Institute of Medicine (U.S) Committee on the Impact of War in the Countries of the Former Yugoslavia","author":"Schaller","year":"1994"},{"key":"10.1016\/j.gheart.2013.08.011_bib51","unstructured":"Benzathine penicillin for syphilis. Coll Pharm B C 2003;27:6."},{"key":"10.1016\/j.gheart.2013.08.011_bib52","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/374338","article-title":"Efficacy of a targeted, oral penicillin-based yaws control program among children living in rural South America","volume":"36","author":"Scolnick","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gheart.2013.08.011_bib53","unstructured":"Blue J. Kids Still Missing Out on Effective Penicillin for Rheumatic Fever. 2008. Available at: http:\/\/www.scoop.co.nz\/stories\/PA0704\/S00363.htm. Accessed January 27,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib54","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2146\/ajhp110210","article-title":"Impact of drug shortages on the U.S. health systems","volume":"68","author":"Kaakeh","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.gheart.2013.08.011_bib55","unstructured":"Douglas J, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention. Availability of Bicillin-LA for Treatment of Syphilis [memo]. August 22, 2005. Available at: http:\/\/www.cdc.gov\/std\/Syphilis\/BicillinLA8-22-05.pdf. Accessed."},{"issue":"Suppl 10","key":"10.1016\/j.gheart.2013.08.011_bib56","doi-asserted-by":"crossref","first-page":"e-2004","DOI":"10.1016\/S0735-1097(13)62004-5","article-title":"Access to essential medicines: illuminating disparities in the global supply of benzathine penicillin G in the context of rheumatic fever\/rheumatic heart disease","volume":"61","author":"Taubert","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2013.08.011_bib57","unstructured":"United Nations Children's Fund. Who is eligible for UNICEF procurement services? [web page]. May 26, 2012. Available at: http:\/\/www.unicef.org\/supply\/index_10363.html. Accessed May 5,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib58","unstructured":"Pham PA, Bartlett JG. HIV Guide\u2014Zambia [web page]. October 20, 2010. Available from: http:\/\/www.zambiahivguide.org\/drugs\/antimicrobial_agents\/benzyl_penicillin.html?contentInstanceId=441458#. Accessed May 13,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib59","unstructured":"Kibira H. Kenya: Heart Foundation Battles Children's Illness [news article]. Star, July 12, 2013 Available at: http:\/\/allafrica.com\/stories\/201307121316.html. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib60","unstructured":"Australian Government, Department of Health and Aging. Benzathine Benzylpenicillin Powder for Injection. 2012. Available at: http:\/\/www.pbs.gov.au\/publication\/schedule\/2013\/08\/2013-08-01-general-schedule.pdf. Accessed July 9,\u00a02012."},{"key":"10.1016\/j.gheart.2013.08.011_bib61","series-title":"Anonymous. Bicillin C-R and Bicillin L-A labels changed to avoid confusion","first-page":"5","year":"2005"},{"key":"10.1016\/j.gheart.2013.08.011_bib62","first-page":"218","article-title":"Inadvertent use of Bicillin C-R to treat syphilis infection\u2014Los Angeles, California, 1999\u20132004","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.gheart.2013.08.011_bib63","unstructured":"Anonymous. Bicillin CR 900\/300. Available at: http:\/\/labeling.pfizer.com\/showlabeling.aspx?id=692 2013. Accessed August 30, 2013."},{"key":"10.1016\/j.gheart.2013.08.011_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0974-2069.79616","article-title":"Global research priorities in rheumatic fever and rheumatic heart disease","volume":"4","author":"Carapetis","year":"2011","journal-title":"Ann Paediatr Cardiol"},{"key":"10.1016\/j.gheart.2013.08.011_bib65","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/INF.0b013e318259b75c","article-title":"Benzathine penicillin G: a documentably important antibiotic in need of a tune up?","volume":"317","author":"Kaplan","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.gheart.2013.08.011_bib66","doi-asserted-by":"crossref","first-page":"e25308","DOI":"10.1371\/journal.pone.0025308","article-title":"Serum penicillin G levels are lower than expect in adults within two weeks of administration of 1.2 million units","volume":"6","author":"Broderick","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gheart.2013.08.011_bib67","unstructured":"Health Canada. Notice of Compliance Search Results. 2012. Available at: http:\/\/webprod5.hc-sc.gc.ca\/noc-ac\/search-recherche.do?lang=eng. Accessed July 12,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib68","unstructured":"World Health Organization. WHO Model Prescribing Information: Drugs Used in the Treatment of Streptococcal Pharyngitis and Prevention of Rheumatic Fever [pdf]. 1999. Available at: http:\/\/apps.who.int\/medicinedocs\/pdf\/s2252e\/s2252e.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jcpt.12014","article-title":"Benzathine penicillin G: a model for long-term pharmacokinetic comparison of parenteral long-acting formulations","volume":"38","author":"Shahbazi","year":"2013","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.gheart.2013.08.011_bib70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/009885881203800403","article-title":"Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs","volume":"38","author":"Hottinger","year":"2012","journal-title":"Am J Law Med"},{"key":"10.1016\/j.gheart.2013.08.011_bib71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/INF.0b013e31825051d4","article-title":"Factors associated with loss of penicillin G concentrations in serum after intramuscular benzathine penicillin G injection: a meta-analysis","volume":"31","author":"Broderick","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.gheart.2013.08.011_bib72","first-page":"1308","article-title":"Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. International Rheumatic Fever Study Group","volume":"337","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2013.08.011_bib73","first-page":"2000","article-title":"Benzathine penicillin: three fatal reports following mega unit injections","volume":"4","author":"World Health Organization","year":"2000","journal-title":"Drug Inform Bull"},{"key":"10.1016\/j.gheart.2013.08.011_bib74","first-page":"109","article-title":"Global eradication of yaws: neglected disease with research priority","volume":"10","author":"Amin","year":"2009","journal-title":"J\u00a0Med"},{"key":"10.1016\/j.gheart.2013.08.011_bib75","unstructured":"Public Health Agency of Canada. Protocol for the Preparation of Benzathine Penicillin [web page]. August 10, 2006. Available at: http:\/\/www.phac-aspc.gc.ca\/std-mts\/protocol-eng.php. Accessed May 13,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib76","series-title":"Pan benzathine administration. In: Best Practice Communique","author":"Gov","year":"2007"},{"key":"10.1016\/j.gheart.2013.08.011_bib77","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(03)13375-2","article-title":"25 years of the WHO essential medicines list: progress and challenges","volume":"361","author":"Laing","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2013.08.011_bib78","unstructured":"van dem Ham R, Bero L, Laing R. The World Medicines Situation 2011: Selection of Essential Medicines [pdf]. 2011. Available at: http:\/\/apps.who.int\/medicinedocs\/documents\/s18770en\/s18770en.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib79","unstructured":"World Health Organization, International Planned Parenthood Federation, John Snow Inc., PATH, Population Services International, United Nations Population Fund, World Bank. The Interagency List of Essential Medicines for Reproductive Health [pdf]. 2006. Available at: http:\/\/whqlibdoc.who.int\/hq\/2006\/WHO_PSM_PAR_2006.1_eng.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib80","unstructured":"World Health Organization. The Selection and Use of Essential Medicines: Report of the WHO Expert Committee. October 2007 (including the Model List of Essential Medicines for Children) [pdf]. WHO Technical Report Series 950. 2008. Available at: http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_950_eng.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib81","unstructured":"World Health Organization. WHO Model List of Essential Medicines. 18th List, April 2013. Available at: http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/18th_EML_Final_web_8Jul13.pdf. Accessed August 20, 2013."},{"key":"10.1016\/j.gheart.2013.08.011_bib82","unstructured":"Beggs S, Peterson G, Tompson A. Antibiotic Use for the Prevention and Treatment of Rheumatic Fever and Rheumatic Heart Disease in Children: Report for the 2nd Meeting of World Health Organization's Subcommittee of the Selection and Use of Essential Medicines [pdf]. September 29 to October 3, 2008. Available at: http:\/\/www.who.int\/selection_medicines\/committees\/subcommittee\/2\/RheumaticFever_review.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2458-13-131","article-title":"Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study","volume":"13","author":"Gasse","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.gheart.2013.08.011_bib84","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1546-0096-8-22","article-title":"Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever","volume":"8","author":"Pelajo","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.gheart.2013.08.011_bib85","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1467-842X.2005.tb00243.x","article-title":"Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community","volume":"29","author":"Eissa","year":"2005","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.gheart.2013.08.011_bib86","first-page":"603","article-title":"[Rheumatic heart disease in children in Brazzaville]","volume":"68","author":"Kimbally-Kaky","year":"2008","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.gheart.2013.08.011_bib87","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5830\/CVJA-2013-022","article-title":"Benzathine penicillin adherence for secondary prophylaxis among heart patients affected with rheumatic heart disease attending Mulago Hospital","volume":"24","author":"Musoke","year":"2013","journal-title":"Cardiovasc J Africa"},{"key":"10.1016\/j.gheart.2013.08.011_bib88","first-page":"140","article-title":"Benzathine penicillin prophylaxis in children with rheumatic fever\/rheumatic heart disease: a study of compliance","volume":"3","author":"Tullu","year":"2010","journal-title":"Al Ameen J Med Sci"},{"key":"10.1016\/j.gheart.2013.08.011_bib89","first-page":"39","article-title":"Barriers to effective follow-up treatment for rheumatic heart disease in Jimma, Ethiopia: a grounded theory analysis of the patient experience","volume":"19","author":"Petricca","year":"2009","journal-title":"Ethiopian J Health Sci"},{"key":"10.1016\/j.gheart.2013.08.011_bib90","unstructured":"Counties Manakau District Health Board. Procedure: Administration of Bicillin Injections in the Community [pdf]. 2011. Available at: http:\/\/www.heartfoundation.org.nz\/uploads\/Administration%20of%20Bicillin%20Injections%20in%20the%20Community%20-%20Procedure.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib91","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00006454-199810000-00008","article-title":"Lidocaine as a diluent for administration of benzathine penicillin G","volume":"17","author":"Amir","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.gheart.2013.08.011_bib92","first-page":"236","article-title":"Lidocaine as a dilutant for benzathine penicillin G reduces injection pain in patients with rheumatic fever: a prospective, randomized, double-blinded crossover study","volume":"6","author":"Morsy","year":"2012","journal-title":"Australian J Basic Appl Sci"},{"key":"10.1016\/j.gheart.2013.08.011_bib93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5694\/mja12.10980","article-title":"The future of rheumatic fever and rheumatic heart disease in Australia","volume":"197","author":"Maguire","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.gheart.2013.08.011_bib94","first-page":"21","article-title":"A\u00a0new insight about pharmaceutical dosage forms for benzathine penicillin G","volume":"27","author":"Holnda e Silva","year":"2006","journal-title":"J\u00a0Basic Appl Pharm Sci"},{"key":"10.1016\/j.gheart.2013.08.011_bib95","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrcardio.2013.34","article-title":"Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease","volume":"10","author":"Remenyi","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.gheart.2013.08.011_bib96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrcardio.2012.157","article-title":"Screening for rheumatic heart disease: current approaches and controversies","volume":"10","author":"Roberts","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.gheart.2013.08.011_bib97","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11536390-000000000-00000","article-title":"Pharmacovigilance activities in 55 low- and-middle income countries: a questionnaire-based analysis","volume":"33","author":"Ossen","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.gheart.2013.08.011_bib98","unstructured":"UNITAID. Annual Report 2011: Five Years of Innovation for Better Health [pdf]. 2011. Available at: http:\/\/www.unitaid.eu\/images\/Annual_Report_2011\/UNITAID_AR2011_EN.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib99","unstructured":"United Nations Children's Fund. Supply Annual Report 2011 [pdf]. 2011. Available at: http:\/\/www.unicef.org\/supply\/files\/UNICEF_Supply_Annual_Report_2011_web.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib100","unstructured":"Medicines Patent Pool. Annual Report 2010\u20132011 [pdf]. 2011. Available at: http:\/\/www.medicinespatentpool.org\/wp-content\/uploads\/Medicines-Patent-Pool-Annual-Report-2010-2011-RevFinal.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib101","unstructured":"Drugs for Neglected Diseases Initiative. 2011 Annual Report: Towards Sustainable Change for Neglected Patients [pdf]. 2011. Available at: http:\/\/www.dndi.org\/images\/stories\/annual_report\/2011\/DNDi_Annual%20report%202011_low-res.pdf. Accessed."},{"key":"10.1016\/j.gheart.2013.08.011_bib102","unstructured":"Stop Stock-Outs! Ensure Access to Essential Medicines for All [pdf]. 2013. Available at: http:\/\/stopstockouts.org\/. Accessed May 25,\u00a02013."},{"key":"10.1016\/j.gheart.2013.08.011_bib103","article-title":"Access to medicines from a health system perspective","author":"Bigdeli","year":"2012","journal-title":"Health Policy Plan"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816013001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816013001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2013.08.011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T08:48:07Z","timestamp":1657529287000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.1016\/j.gheart.2013.08.011\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":103,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2013.08.011","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,1]]}}}